Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Chemotherapy-induced Febrile Neutropenia
Sponsor: Amgen